Ligand Set For Partnership Opportunities After Completing On Pfenex

Sets Out Strategy And Revenue Drivers After Finalizing $500m Deal

 
• By Dave Wallace

Fresh from completing its acquisition of Pfenex, Ligand Pharmaceuticals has laid out the benefits that it expects to gain from the deal.    

Open door
THE PFENEX DEAL OPENS THE DOOR TO AT LEAST THREE NEW PARTNERSHIPS IN THE NEXT 12 MONTHS • Source: Shutterstock

More from Deals

More from Business